Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K/A | 10-K/A |
| Revenues: |
| Europe | 20.3 | 14.3 | 51.0 | 70.8 | 29.4 | | | |
| United States | | | | 58.7 | 26.2 | 78.3 | 30.9 | 7.1 |
| Brazil | | | | 3.7 | 0.9 | 2.2 | 0.5 | 5.0 |
| Other | 249.5 | 327.5 | 122.1 | 19.4 | 7.0 | 47.2 | 35.8 | 22.0 |
| Total revenues | 269.8 | 341.8 | 173.1 | 152.6 | 63.6 | 127.7 | 67.2 | 34.2 |
| Revenue growth [+] | -21.1% | 97.4% | 13.5% | 139.9% | -50.2% | 90.0% | 96.7% | -21.1% |
| Europe | 42.0% | -71.9% | -28.0% | 140.8% | | | | |
| United States | | | | 123.6% | -66.5% | 153.0% | 334.5% | -66.6% |
| Brazil | | | | 295.6% | -56.4% | 342.4% | -90.2% | -16.1% |
| Cost of goods sold | 258.7 | 155.1 | 87.8 | 76.2 | 36.7 | 62.3 | 56.7 | 37.4 |
| Gross profit | 11.2 | 186.7 | 85.3 | 76.4 | 26.9 | 65.4 | 10.5 | -3.2 |
| Gross margin | 4.1% | 54.6% | 49.3% | 50.1% | 42.3% | 51.2% | 15.6% | -9.4% |
| Selling, general and administrative | 493.6 | 257.8 | 137.1 | 126.6 | 90.9 | 63.9 | 47.7 | 56.3 |
| Research and development | 110.2 | 94.3 | 71.7 | 71.5 | 68.7 | 57.6 | 51.4 | 44.6 |
| Equity in earnings | | | | | | | | -4.2 |
| Other operating expenses | | | | | 5.6 | -5.7 | | 8.5 |
| EBITDA [+] | -580.3 | -156.7 | -114.1 | -117.1 | -133.4 | -39.0 | -77.2 | -103.9 |
| EBITDA growth | 270.4% | 37.4% | -2.6% | -12.3% | 242.5% | -49.6% | -25.7% | 22.7% |
| EBITDA margin | -215.0% | -45.8% | -65.9% | -76.8% | -209.8% | -30.5% | -115.0% | -304.3% |
| Depreciation | 7.9 | 7.8 | 9.4 | 4.6 | 4.9 | 11.4 | 11.4 | 12.9 |
| EBITA | -588.2 | -164.4 | -123.4 | -121.7 | -138.4 | -50.3 | -88.6 | -116.9 |
| EBITA margin | -218.0% | -48.1% | -71.3% | -79.8% | -217.5% | -39.4% | -131.9% | -342.1% |
| Amortization of intangibles | 4.4 | 1.0 | | | | | | |
| EBIT [+] | -592.7 | -165.4 | -123.4 | -121.7 | -138.4 | -50.3 | -88.6 | -116.9 |
| EBIT growth | 258.3% | 34.0% | 1.4% | -12.1% | 175.0% | -43.2% | -24.2% | 17.2% |
| EBIT margin | -219.6% | -48.4% | -71.3% | -79.8% | -217.5% | -39.4% | -131.9% | -342.1% |
| Non-recurring items [+] | -23.7 | 12.2 | | 0.2 | -1.8 | 5.7 | 7.3 | 35.9 |
| Asset impairment | | 12.2 | | 0.2 | | | 7.3 | 39.7 |
| Loss (gain) on disposal of assets | | | | | -1.8 | 5.7 | | |
| Interest expense | 24.7 | 25.6 | 48.0 | 58.7 | 42.7 | 37.1 | 37.6 | 78.9 |
| Interest expense | 24.7 | 25.6 | 48.0 | 58.7 | 42.7 | 37.1 | 37.6 | 78.9 |
| Other income (expense), net [+] | 55.1 | -69.1 | -152.5 | -61.6 | -50.9 | -56.0 | 36.8 | 18.2 |
| Gain (loss) on debt retirement | | -32.5 | -52.0 | -44.2 | -17.4 | -11.9 | -4.1 | -1.1 |
| Unrealized gain/loss on derivatives | 3.9 | 1.5 | -11.4 | 2.8 | -30.9 | -48.9 | 41.4 | 16.3 |
| Other | -2.2 | 0.6 | 0.7 | -0.8 | -2.9 | -1.0 | -0.4 | -1.2 |
| Pre-tax income | -538.6 | -272.3 | -323.9 | -242.1 | -230.2 | -149.1 | -96.8 | -213.4 |
| Income taxes | 2.7 | 8.1 | -0.3 | 0.6 | 0.0 | 6.9 | 0.6 | 0.5 |
| Tax rate | | | 0.1% | | 0.0% | | | |
| Minority interest | -14.9 | -0.8 | 4.2 | | | | | -0.1 |
| Net income | -528.5 | -270.5 | -382.3 | -270.4 | -223.1 | -201.9 | -97.3 | -218.0 |
| Net margin | -195.9% | -79.1% | -220.8% | -177.2% | -350.8% | -158.1% | -144.9% | -638.2% |
| |
| Basic EPS [+] | ($1.65) | ($0.93) | ($1.88) | ($2.67) | ($3.69) | ($6.26) | ($6.12) | ($25.75) |
| Growth | 78.1% | -50.7% | -29.6% | -27.7% | -41.0% | 2.2% | -76.2% | -27518.4% |
| Diluted EPS [+] | ($1.56) | ($0.92) | ($1.88) | ($2.67) | ($3.69) | ($6.26) | ($5.52) | ($25.75) |
| Growth | 68.5% | -50.8% | -29.6% | -27.8% | -41.0% | 13.4% | -78.6% | -42717.1% |
| |
| Shares outstanding (basic) [+] | 320.8 | 292.3 | 203.6 | 101.3 | 60.4 | 32.3 | 15.9 | 8.5 |
| Growth | 9.7% | 43.6% | 101.0% | 67.7% | 87.3% | 102.9% | 87.8% | -89.2% |
| Shares outstanding (diluted) [+] | 339.3 | 292.7 | 203.6 | 101.4 | 60.4 | 32.3 | 17.6 | 8.5 |
| Growth | 15.9% | 43.7% | 100.8% | 67.8% | 87.3% | 82.8% | 108.4% | -93.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|